Citadel Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.5M Sell
74,505
-177,009
-70% -$8.32M ﹤0.01% 2220
2025
Q1
$11.1M Sell
251,514
-121,717
-33% -$5.37M ﹤0.01% 1188
2024
Q4
$13.5M Buy
373,231
+242,525
+186% +$8.76M ﹤0.01% 1143
2024
Q3
$4.19M Buy
130,706
+32,755
+33% +$1.05M ﹤0.01% 1913
2024
Q2
$3.69M Sell
97,951
-612,316
-86% -$23.1M ﹤0.01% 1917
2024
Q1
$35M Buy
710,267
+292,453
+70% +$14.4M 0.01% 618
2023
Q4
$15.3M Buy
417,814
+396,508
+1,861% +$14.5M ﹤0.01% 988
2023
Q3
$493K Buy
21,306
+13,225
+164% +$306K ﹤0.01% 3768
2023
Q2
$212K Sell
8,081
-25,872
-76% -$678K ﹤0.01% 4400
2023
Q1
$874K Sell
33,953
-92,993
-73% -$2.39M ﹤0.01% 3312
2022
Q4
$3.3M Sell
126,946
-40,049
-24% -$1.04M ﹤0.01% 2158
2022
Q3
$4.77M Buy
166,995
+37,580
+29% +$1.07M ﹤0.01% 1902
2022
Q2
$3.19M Buy
129,415
+102,516
+381% +$2.52M ﹤0.01% 2296
2022
Q1
$1.52M Sell
26,899
-27,283
-50% -$1.54M ﹤0.01% 3309
2021
Q4
$3.36M Sell
54,182
-117,954
-69% -$7.31M ﹤0.01% 2510
2021
Q3
$10.9M Sell
172,136
-639,889
-79% -$40.6M ﹤0.01% 1363
2021
Q2
$66.9M Buy
812,025
+10,634
+1% +$876K 0.02% 376
2021
Q1
$59M Buy
801,391
+8,605
+1% +$633K 0.01% 400
2020
Q4
$57.5M Buy
792,786
+34,207
+5% +$2.48M 0.01% 374
2020
Q3
$36.2M Sell
758,579
-166,102
-18% -$7.92M 0.01% 508
2020
Q2
$38.8M Sell
924,681
-18,614
-2% -$782K 0.01% 470
2020
Q1
$25.5M Buy
943,295
+12,426
+1% +$336K 0.01% 562
2019
Q4
$35.8M Sell
930,869
-392,948
-30% -$15.1M 0.02% 555
2019
Q3
$28.7M Buy
+1,323,817
New +$28.7M 0.01% 641